Creating a colony-forming unit commonly starts with adding around 15 ml of molten agar to around 1 ml of bacterial culture in ...

Celcuity's gedatolisib, a dual PI3K/mTOR inhibitor, shows promise in Phase 3 breast cancer trials. Click here to read an ...

Compugen's innovative approach targets under-explored immune pathways like PVRIG and IL-18 binding protein. Read why I'm ...

Inhibition of nonsense-mediated decay turns immunologically cold tumors hot by increasing the amount of mutant RNA leading to an increase in T-cell-targetable neoantigens on the cell surface.

Topline data were announced from a phase 3 trial evaluating Keytruda plus Lenvima with chemotherapy in advanced gastroesophageal cancer.

The team at USA TODAY attended 45 shows, events, parties and presentations. Here's a glimpse and what we saw and heard all of New York Fashion Week.

This can include: being rude saying things that aren’t appropriate (for example, that someone is overweight) talking to strangers undressing in public apparent loss of sexual inhibition (for example, ...

BMO Capital Markets adjusted its stance on Q32 Bio Inc. (NASDAQ: QTTB), downgrading the biotechnology firm's stock rating from Outperform to Market Perform, accompanied by a significant decrease in ...

Anna Sui turned her eye to the world of the "madcap heiress" from the 1930s, a woman who the society pages of the time would ...

Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...

“This current administration is like nothing that we've seen before,” said a managing partner of a global venture capital firm who spoke to BioWorld on the condition of anonymity. “President Trump’s ...

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday. Shares of Brinker International, Inc. EAT gained 12.8% to $174.33 after the company reported better-than-expected ...